Weekly News Round-up – 26/2/21
In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...
4 years agoWeekly News Round-up – 26/2/21
In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...
4 years ago
The Promise of Quantum AI in Pharma R&D
Given the long-standing hype around AI and machine learning (ML) in pharma R&D, it can be easy to overlook innovations that potentially promise just as much for the pharmaceutical sector. Quantum computing is one area expected to have far-reaching impact...
4 years agoThe Promise of Quantum AI in Pharma R&D
Given the long-standing hype around AI and machine learning (ML) in pharma R&D, it can be easy to overlook innovations that potentially promise just as much for the pharmaceutical sector. Quantum computing is one area expected to have far-reaching impact...
4 years ago
Weekly News Round-up – 19/2/21
PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...
4 years agoWeekly News Round-up – 19/2/21
PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...
4 years ago
A Look Ahead: Clinical Trials and PV Over the Next 5 Years
Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...
4 years agoA Look Ahead: Clinical Trials and PV Over the Next 5 Years
Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...
4 years ago
Weekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
4 years agoWeekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
4 years ago
Weekly News Round-up – 22/1/21
In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...
4 years agoWeekly News Round-up – 22/1/21
In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...
4 years ago
The Importance of Efficacy in COVID-19 Vaccines
With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...
4 years agoThe Importance of Efficacy in COVID-19 Vaccines
With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...
4 years ago
Weekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years agoWeekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years ago
Weekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years agoWeekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years ago
Why the Decline in Pharma R&D?
For a few decades now there has been a narrative in the pharmaceutical sector that R&D productivity has been steadily declining: thanks to a lack of low-hanging fruit, blockbuster drugs have been harder and harder to find. AI promises a...
4 years agoWhy the Decline in Pharma R&D?
For a few decades now there has been a narrative in the pharmaceutical sector that R&D productivity has been steadily declining: thanks to a lack of low-hanging fruit, blockbuster drugs have been harder and harder to find. AI promises a...
4 years ago